CUE
Cue Biopharma
25.50$
-7.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Cue Biopharma (CUE) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/21/2026 | Current report (8-K) | Cue Biopharma, Inc. (CUE): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Current report (8-K) | Cue Biopharma, Inc. (CUE): Results of Operations and Financial Condition | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.